MSD's etanercept, BRENZYS, will become the first biosimilar listed with new uptake drivers on 1 December. …
Latest Video
New Stories
-
Forum to consider new approach to cancer medicines
April 26, 2019 - - Latest News -
Expansion in the US but still no news on Australia and NZ
April 26, 2019 - - Latest News -
Election means 'wait' for NPS review outcome
April 26, 2019 - - Latest News -
CAR-T assessment is evidence of the need for change
April 24, 2019 - - Latest News -
Discussions on process improvements grind to a halt
April 24, 2019 - - Latest News -
Overseas access funded as patients await local approval
April 24, 2019 - - Latest News -
New details confirm pre-election rush to approve CAR-T
April 23, 2019 - - Latest News